Abstract
Inducible acetylation of p53 at lysine residues has a great impact on regulating the transactivation of this protein, which is associated with cell growth arrest and/or apoptosis under various stress conditions. However, the factor(s) for regulating p53 acetylation remains largely unknown. In the current study, we have shown that p85α, the regulatory subunit of phosphatidylinositol-3-kinase, has a critical role in mediating p53 acetylation and promoter-specific transactivation in the ultraviolet B (UVB) response. Depletion of p85α in mouse embryonic fibroblasts significantly impairs UVB-induced apoptosis, as well as p53 transactivation and acetylation at Lys370 (Lys373 of human p53); however, the accumulation, nuclear translocation and phosphorylation of p53 are not affected. Interestingly, p85α binds to p300, promotes the p300–p53 interaction and the subsequent recruitment of the p53/p300 complex to the promoter region of the specific p53 target gene in response to UVB irradiation. Moreover, ablation of p53 acetylation at Lys370 by site-directed mutagenesis dramatically suppresses UVB-induced expression of the specific p53-responsive gene as well as cell apoptosis. Therefore, we conclude that p85α is a novel regulator of p53-mediated response under certain stress conditions, and targeting the p85α-dependent p53 pathway may be promising for cancer therapy.
Similar content being viewed by others
References
An W, Kim J, Roeder RG . (2004). Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell 117: 735–748.
Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS, Kelly K . (1997). Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89: 1175–1184.
Brooks CL, Gu W . (2003). Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15: 164–171.
Brooks CL, Gu W . (2008). p53 activation: a case against Sir. Cancer Cell 13: 377–378.
Cao C, Lu S, Kivlin R, Wallin B, Card E, Bagdasarian A et al. (2008). SIRT1 confers protection against UVB- and H(2)O(2)-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J Cell Mol Med 4: 4.
Chao C, Wu Z, Mazur SJ, Borges H, Rossi M, Lin T et al. (2006). Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol Cell Biol 26: 6859–6869.
Eischen CM, Lozano G . (2009). p53 and MDM2: antagonists or partners in crime? Cancer Cell 15: 161–162.
Feng L, Lin T, Uranishi H, Gu W, Xu Y . (2005). Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol 25: 5389–5395.
Geering B, Cutillas PR, Vanhaesebroeck B . (2007). Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits? Biochem Soc Trans 35: 199–203.
Goodman RH, Smolik S . (2000). CBP/p300 in cell growth, transformation, and development. Genes Dev 14: 1553–1577.
Grossman SR . (2001). p300/CBP/p53 interaction and regulation of the p53 response. Eur J Biochem 268: 2773–2778.
Gu W, Roeder RG . (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595–606.
Haupt Y, Maya R, Kazaz A, Oren M . (1997). Mdm2 promotes the rapid degradation of p53. Nature 387: 296–299.
Iyer NG, Ozdag H, Caldas C . (2004). p300/CBP and cancer. Oncogene 23: 4225–4231.
Juan L-J, Shia W-J, Chen M-H, Yang W-M, Seto E, Lin Y-S et al. (2000). Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem 275: 20436–20443.
Kim EJ, Kho JH, Kang MR, Um SJ . (2007). Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 28: 277–290.
Kitagawa M, Lee SH, McCormick F . (2008). Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Mol Cell 29: 217–231.
Kruse JP, Gu W . (2009). Modes of p53 regulation. Cell 137: 609–622.
Kubbutat MHG, Jones SN, Vousden KH . (1997). Regulation of p53 stability by Mdm2. Nature 387: 299–303.
Kurash JK, Lei H, Shen Q, Marston WL, Granda BW, Fan H et al. (2008). Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol Cell 29: 392–400.
Lain S, Hollick JJ, Campbell J, Staples OD, Higgins M, Aoubala M et al. (2008). Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell 13: 454–463.
Latonen L, Laiho M . (2005). Cellular UV damage responses—functions of tumor suppressor p53. Biochim Biophys Acta 1755: 71–89.
Levine AJ, Hu W, Feng Z . (2006). The P53 pathway: what questions remain to be explored? Cell Death Differ 13: 1027–1036.
Li M, Luo J, Brooks CL, Gu W . (2002). Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277: 50607–50611.
Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM . (1997). Binding and modulation of p53 by p300/CBP coactivators. Nature 387: 823–827.
Liu G, Chen X . (2006). Regulation of the p53 transcriptional activity. J Cell Biochem 97: 448–458.
Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD et al. (1999). p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19: 1202–1209.
Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC . (2005). The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J Cell Biol 170: 455–464.
Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W . (2004). Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Prog Natl Acad Sci USA 101: 2259–2264.
Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A et al. (2001). Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137–148.
Luo J, Su F, Chen D, Shiloh A, Gu W . (2000). Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377–381.
Manning BD, Cantley LC . (2007). AKT/PKB signaling: navigating downstream. Cell 129: 1261–1274.
Miled N, Yan Y, Hon WC, Perisic O, Zvelebil M, Inbar Y et al. (2007). Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317: 239–242.
Olsson A, Manzl C, Strasser A, Villunger A . (2007). How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ 14: 1561–1575.
Pan X, Zhao J, Zhang WN, Li HY, Mu R, Zhou T et al. (2009). Induction of SOX4 by DNA damage is critical for p53 stabilization and function. Proc Natl Acad Sci USA 106: 3788–3793.
Pedeux R, Sengupta S, Shen JC, Demidov ON, Saito S, Onogi H et al. (2005). ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol Cell Biol 25: 6639–6648.
Reczek EE, Flores ER, Tsay AS, Attardi LD, Jacks T . (2003). Multiple response elements and differential p53 binding control Perp expression during apoptosis. Mol Cancer Res 1: 1048–1057.
Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A et al. (1998). DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12: 2831–2841.
Sasaki T, Gan EC, Wakeham A, Kornbluth S, Mak TW, Okada H . (2007). HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev 21: 848–861.
Song L, Li J, Hu M, Huang C . (2008). Both IKKalpha and IKKbeta are implicated in the arsenite-induced AP-1 transactivation correlating with cell apoptosis through NF-kappaB activity-independent manner. Exp Cell Res 314: 2187–2198.
Song L, Li J, Ye J, Yu G, Ding J, Zhang D et al. (2007). p85alpha acts as a novel signal transducer for mediation of cellular apoptotic response to UV radiation. Mol Cell Biol 27: 2713–2731.
Song L, Li J, Zhang D, Liu ZG, Ye J, Zhan Q et al. (2006). IKKbeta programs to turn on the GADD45alpha-MKK4-JNK apoptotic cascade specifically via p50 NF-kappaB in arsenite response. J Cell Biol 175: 607–617.
Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS et al. (2006). Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 24: 841–851.
Tang Y, Luo J, Zhang W, Gu W . (2006). Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 24: 827–839.
Tang Y, Zhao W, Chen Y, Zhao Y, Gu W . (2008). Acetylation is indispensable for p53 activation. Cell 133: 612–626.
Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR . (2002a). Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol 22: 965–977.
Ueki K, Yballe CM, Brachmann SM, Vicent D, Watt JM, Kahn CR et al. (2002b). Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase. Proc Natl Acad Sci USA 99: 419–424.
Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK et al. (2001). hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149–159.
Wang J, Ouyang W, Li J, Wei L, Ma Q, Zhang Z et al. (2005). Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor {kappa}B induced by UV radiation. Cancer Res 65: 6601–6611.
Yin Y, Terauchi Y, Solomon GG, Aizawa S, Rangarajan PN, Yazaki Y et al. (1998). Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 391: 707–710.
Zhao W, Kruse JP, Tang Y, Jung SY, Qin J, Gu W . (2008). Negative regulation of the deacetylase SIRT1 by DBC1. Nature 451: 587–590.
Zhu Z, Luo Z, Li Y, Ni C, Li H, Zhu M . (2009). Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology 49: 504–512.
Acknowledgements
We appreciate the technical help from Dr Dan Liu and the helpful discussion provided by Dr Ailing Li. This project is partially supported by NIH/NCI CA112557, CA119028-05S110, NIH/NIEHS ES010344 and ES012451 (to Dr C Huang); and National Natural Science Foundation of China No. 30871277, 30970594, Beijing Natural Science Foundation 5092022 and 5102035 and the National Key Research and Development Programs on Fundamental Sciences (973 Project) 2011CB503803 (to Dr L Song).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Song, L., Gao, M., Dong, W. et al. p85α mediates p53 K370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular UVB response. Oncogene 30, 1360–1371 (2011). https://doi.org/10.1038/onc.2010.506
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.506
- Springer Nature Limited
Keywords
This article is cited by
-
Isorhapontigenin (ISO) inhibits stem cell-like properties and invasion of bladder cancer cell by attenuating CD44 expression
Cellular and Molecular Life Sciences (2020)
-
Potential molecular characteristics in situ in response to repetitive UVB irradiation
Diagnostic Pathology (2016)